NICHOLAS MACPHERSON: Open Payments
NPI 1497097984 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 51 payments from 15 companies in 2025. Trend: 2023 $950 · 2024 $1,554 · 2025 $1,877
Food & beverage: $1,877
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 9 | $517 |
| Endologix LLC | 1 | $350 |
| HEARTFLOW, INC. | 6 | $229 |
| Novartis Pharmaceuticals Corporation | 10 | $224 |
| PFIZER INC. | 7 | $128 |
| BridgeBio Pharma, Inc. | 3 | $86 |
| Abbott Laboratories | 3 | $84 |
| Amgen Inc. | 4 | $65 |
| Stryker Corporation | 1 | $46 |
| Merck Sharp & Dohme LLC | 2 | $38 |
Products named: Cleerly Ischemia, Alto Abdominal Stent Graft System, FFRct, LEQVIO, VYNDAQEL, Attruby, REPATHA, ELIQUIS.
Industry payments across TX — which companies pay providers there.
